Health & Fitness
Health and Fitness
Health and Fitness
Mon, February 7, 2011Sun, February 6, 2011Fri, February 4, 2011Thu, February 3, 2011Wed, February 2, 2011Tue, February 1, 2011Mon, January 31, 2011Sun, January 30, 2011Fri, January 28, 2011Thu, January 27, 2011Wed, January 26, 2011Tue, January 25, 2011Mon, January 24, 2011Sun, January 23, 2011Sat, January 22, 2011Fri, January 21, 2011Thu, January 20, 2011Wed, January 19, 2011Tue, January 18, 2011Mon, January 17, 2011Fri, January 14, 2011Thu, January 13, 2011Wed, January 12, 2011Tue, January 11, 2011Mon, January 10, 2011Covidien Delivers 20,000th ForceTriadTM Energy Platform
Published in Health and Fitness on Wednesday, January 26th 2011 at 13:05 GMT by Market Wire
BOULDER, Colo.--([ BUSINESS WIRE ])--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the delivery of the Company's 20,000th ForceTriada" energy platform. The Dongzhimen Hospital, an affiliate of Beijing University of Chinese Medicine, in Beijing, China, took delivery of the device earlier this month. Known for its teaching and clinical research, Dongzhimen Hospital embraces both Chinese and Western medicine in serving the healthcare needs of its patients and the community.
"Where surgeons once used traditional mechanical methods, they now routinely use energy to cut and fuse tissue."
The ForceTriad energy platform, which is used in combination with a variety of hand-held surgical devices, enables surgeons to use energy to achieve a range of tissue effects, including dissection and vessel fusion. Since its launch in 2006, the ForceTriad platform has been placed into service in hospitals in 94 countries.
"The purchase of the 20,000th ForceTriad energy platform by the Dongzhimen Hospital reflects Covidien's global expansion in energy devices," said Bryan Hanson, President, Energy-based Devices, Covidien. "Where surgeons once used traditional mechanical methods, they now routinely use energy to cut and fuse tissue."
The ForceTriad platform uses enhanced LigaSurea" tissue fusion technology to permanently fuse vessels, lymphatics, tissue bundles and pulmonary vasculature. This unit is used in a wide variety of surgical procedures, including many urologic and gynecologic procedures, such as hysterectomies.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit [ www.covidien.com ] to learn more about our business.
